Search Results for "ONS on call"

Hypercalcemia of malignancy (HCM) affects about 30% of all patients with cancer. Patients with breast cancer that has metastasized to bone and patients with squamous cell lung cancer together account for more than half of all HCM cases. ONS member Marcelle Kaplan, RN, MS, CNS, CBCN^®–Emeritus, AOCN^®–Emeritus, breast oncology clinical specialist, and Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, discuss hypercalcemia of malignancy and its current treatment strategies. This episode is part of a series about oncologic emergencies; the other episodes are linked in the episode notes. 

Somatic biomarker testing reports can be complex, yet nurses need to understand possible outcomes and their implications for practice. This easy-to-read table outlines some of the potential outcomes of somatic biomarker testing, clarifies the meaning of the findings, and relates those to actions nurses can implement.

Somatic biomarker testing reports can be complex. As a nurse, you will review these reports and identify pertinent content to provide optimal patient care. Use this checklist to get familiar with the reports to ensure you are reviewing the applicable information. The Nursing Implications Based on Somatic Biomarker Testing Outcomes resource can be used to complement the checklist and increase your understanding of test findings.

Nurses play an essential role in supporting the somatic biomarker testing process from specimen collection to providing education on treatment decisions based on the outcomes. This resource outlines the implications for nursing practice and defines the role of the oncology nurse in this process.

Cardiac tamponade typically presents gradually over time, and it can happen multiple times throughout a patient’s cancer care journey. Oncology nurses must stay cognizant of the warning signs and management approaches. ONS member Roberta Kaplow, RN, PhD, CCRN, AOCNS^®, clinical nurse specialist at Emory University Hospital in Atlanta, GA, and member of the Metro Atlanta ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the latest nursing management and prevention strategies for cardiac tamponade. This episode is part of a series about oncologic emergencies; the previous ones are linked in the episode notes.

A new class of drugs, antibody-drug conjugates, combines the specificity of targeted therapy with the cytotoxicity of chemotherapy for a powerhouse effect against certain types of cancer variants. Here’s what you need to know about this novel treatment modality.

Nurses may need to collect additional information from the laboratory being used for biomarker testing to help educate patients and families and inform nursing practice.